Product Information
MOEXIPRIL HCL 15 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.0064 per EA under NDC 00093515001. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on May 8, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093515001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MOEXIPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076204FDA Approved
5/8/2003
TE Code
AB
On Market Since
5/8/2003
Pharmacological Classes
Price Statistics
The NADAC for MOEXIPRIL HCL 15 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 99.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0064 per EA |
|---|---|
| All-time high | $1.0064 (Aug 19, 2026) |
| All-time low | $0.5048 (Nov 28, 2013) |
| 52-week high | $1.0064 |
| 52-week low | $0.9627 |
| Median price | $0.8175 |
| Average price | $0.8094 |
| Largest weekly change | +37.0% (Mar 18, 2020) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOEXIPRIL HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MOEXIPRIL HCL 15 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.0064 per EA (NDC 00093515001), effective Aug 19, 2026.
How has the price of MOEXIPRIL HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for MOEXIPRIL HCL 15 MG TABLET has risen 99.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOEXIPRIL HCL 15 MG TABLET?
Since Nov 28, 2013, the NADAC for MOEXIPRIL HCL 15 MG TABLET has ranged from a low of $0.5048 (Nov 28, 2013) to a high of $1.0064 (Aug 19, 2026), with a median of $0.8175 per EA.
Are there cheaper alternatives to MOEXIPRIL HCL 15 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MOEXIPRIL HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MOEXIPRIL HCL 15 MG TABLET?
MOEXIPRIL HCL 15 MG TABLET (NDC 00093515001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.